Longer recurrence free survival (RFS) in germline pathogenic variant (gPV) positive patients with melanoma on adjuvant checkpoint immunotherapy (IO)

被引：0
|
作者：
Shen, A. [1 ]
Arbesman, M. [1 ]
Lodha, R. [1 ]
Buturla, N. [1 ]
Diaz, M. [1 ]
Funchain, P. [1 ]
Arbesman, J. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1243
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 32 条
  • [1] Neoadjuvant immunotherapy (neoIT) in melanoma: A prediction tool for pathological response and recurrence, and the role of adjuvant (Adj) therapy (Tx) to improve recurrence-free survival (RFS)
    Da Silva, Ines Esteves Domingues Pires
    Grover, Piyush
    Adegoke, Nurudeen
    Rawson, Robert V.
    Colebatch, Andrew J.
    Carlino, Matteo S.
    Lo, Serigne N.
    Menzies, Alexander M.
    Scolyer, Richard A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma
    Shen, Alan
    Arbesman, Michelle
    Lodha, Roshan
    Rayman, Patricia
    Bungo, Brandon
    Ni, Ying
    Chan, Timothy
    Gastman, Brian
    Ko, Jennifer
    Diaz-Montero, C. Marcela
    Arbesman, Joshua
    Funchain, Pauline
    CLINICAL CANCER RESEARCH, 2024, 30 (03) : 564 - 574
  • [3] Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Boer, A. M. Stevense-den
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [4] Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
    Paschou, Stavroula A.
    Liontos, Michael
    Eleftherakis-Papaiakovou, Evangelos
    Stefanaki, Katerina
    Markellos, Christos
    Koutsoukos, Konstantinos
    Zagouri, Flora
    Psaltopoulou, Theodora
    Dimopoulos, Meletios-Athanasios
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] 3-Year Results Adjuvant Nivolumab Therapy continues to show longer recurrence-free Survival in High-risk Patients with resected Melanoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 703 - 703
  • [6] Higher proportions of CD39+tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
    Attrill, Grace Heloise
    Owen, Carina N.
    Ahmed, Tasnia
    Vergara, Ismael A.
    Colebatch, Andrew J.
    Conway, Jordan W.
    Nahar, Kazi J.
    Thompson, John F.
    da Silva, Ines Pires
    Carlino, Matteo S.
    Menzies, Alexander M.
    Lo, Serigne
    Palendira, Umaimainthan
    Scolyer, Richard A.
    Long, Georgina, V
    Wilmott, James S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [7] Predicting recurrence-free survival for patients with stage II melanoma: A validated tool to guide selection for adjuvant systemic therapy
    Varey, A. H. R.
    El Sharouni, M-A.
    Simon, J.
    Gershenwald, J. E.
    Long, G. V.
    Scolyer, R. A.
    Thompson, J. F.
    Lo, S. N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S913 - S913
  • [8] HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy
    Bravo, Alicia Ines
    Aris, Mariana
    Panouillot, Marylou
    Porto, Martina
    Dieu-Nosjean, Marie-Caroline
    Teillaud, Jean-Luc
    Barrio, Maria Marcela
    Mordoh, Jose
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] The gut microbiome is associated with recurrence free survival in patients with resected Stage III or Stage IV melanoma treated with immune checkpoint inhibitors
    Usyk, Mykhaylo
    Hayes, Richard B.
    Knight, Rob
    Gonzalez, Antonio
    Li, Huilin
    Osman, Iman
    Weber, Jeffrey S.
    Ahn, Jiyoung
    CANCER RESEARCH, 2024, 84 (06)
  • [10] " Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056]
    Ozkan, A.
    Kapiteijn, E.
    van den Bos, F.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Bloem, M.
    Blokx, W. A. M.
    Boers-Sonderen, M. J.
    Bonenkamp, J. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B.
    Holtslag, C. E.
    Hospers, G. A. P.
    Piersma, D.
    van Rijn, R. S.
    Stevense-den Boer, A. M.
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Portielje, J. E. A.
    de Glas, N. A.
    EUROPEAN JOURNAL OF CANCER, 2025, 216
1234